Three presentations at ADA 2025 highlighted the therapeutic potential of icovamenib across multiple aspects of metabolic health:In patients with type 2 diabetes (T2D) not achieving glycemic targets, ...

SALT LAKE CITY, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding ...

The concept of 24-hour trading is gaining traction as global connectivity and technological advancements drive demand for ...

India's markets regulator on Thursday proposed changes to the structure of large initial public offerings, including ...

Euronext, the leading European capital market infrastructure, today announces the submission of an all-share voluntary share exchange offer (the ‘Offer’) addressed to all shareholders of HELLENIC ...

Euronext to launch voluntary share exchange offer for all ATHEX shares ...